bioAffinity (BIAF) Revenue & Revenue Breakdown
bioAffinity Revenue Highlights
Latest Revenue (Y)
$9.36M
Latest Revenue (Q)
$1.85M
Main Segment (Y)
Health Care, Patient Service
bioAffinity Revenue by Period
bioAffinity Revenue by Year
| Date | Revenue | Change | 
|---|---|---|
| 2024-12-31 | $9.36M | 269.68% | 
| 2023-12-31 | $2.53M | 52627.44% | 
| 2022-12-31 | $4.80K | 100.00% | 
| 2021-12-31 | - | 100.00% | 
| 2020-12-31 | - | 100.00% | 
| 2019-12-31 | - | - | 
bioAffinity generated $9.36M in revenue during NA 2024, up 269.68% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
bioAffinity Revenue by Quarter
| Date | Revenue | Change | 
|---|---|---|
| 2025-03-31 | $1.85M | -16.03% | 
| 2024-12-31 | $2.21M | -6.04% | 
| 2024-09-30 | $2.35M | -2.00% | 
| 2024-06-30 | $2.40M | -0.33% | 
| 2024-03-31 | $2.41M | 8.72% | 
| 2023-12-31 | $2.21M | 641.41% | 
| 2023-09-30 | $298.48K | 1412.23% | 
| 2023-06-30 | $19.74K | 2043.11% | 
| 2023-03-31 | $921.00 | -60.74% | 
| 2022-12-31 | $2.35K | 104.00% | 
| 2022-09-30 | $1.15K | -11.94% | 
| 2022-06-30 | $1.31K | 100.00% | 
| 2022-03-31 | - | 100.00% | 
| 2021-12-31 | - | 100.00% | 
| 2021-09-30 | - | 100.00% | 
| 2021-06-30 | - | 100.00% | 
| 2021-03-31 | - | 100.00% | 
| 2020-12-31 | - | - | 
bioAffinity generated $1.85M in revenue during Q1 2025, up -16.03% compared to the previous quarter, and up 83.78% compared to the same period a year ago.
bioAffinity Revenue Breakdown
bioAffinity Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | 
|---|---|---|
| Health Care, Patient Service | $516.00K | - | 
| Health Care, Other | - | $19.32K | 
| Other Revenues | - | $21.52K | 
Latest
bioAffinity's latest annual revenue breakdown by segment (product or service), as of Dec 24: Health Care, Patient Service (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | 
|---|---|---|---|---|---|---|---|---|
| Health Care, Patient Service | $2.51M | $169.00K | $248.65K | - | - | - | - | - | 
| Other Revenues | $4.38K | $23.92K | $23.92K | $427.00 | - | - | - | - | 
| Health Care, Other | - | - | $50.14K | $33.19K | $16.06K | $16.93K | $2.39K | - | 
| Laboratory Services | - | - | - | - | - | - | $7.42K | - | 
| Royalty Income | - | - | - | - | - | - | $5.41K | - | 
| Diagnostic Test | - | - | - | - | - | - | - | $7.00K | 
Latest
bioAffinity's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Health Care, Patient Service (99.83%), and Other Revenues (0.17%).
bioAffinity Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue | 
|---|---|---|---|
| BIAF | bioAffinity | $9.36M | $1.85M | 
| ISPC | iSpecimen | $9.29M | $1.06M | 
| MNDR | Mobile-health Network Solutions Class A Ordinary Shares | $5.77M | $3.32M | 
| APDN | Applied DNA Sciences | $3.43M | $983.37K | 
| GTBP | GT Biopharma | - | - | 
| INDP | Indaptus Therapeutics | - | - | 
| ARTL | Artelo Biosciences | - | - | 
| PRFX | PainReform | - | - | 
| PTIX | Protagenic Therapeutics | - | - |